emerge health semaglutide GLP-1s may be trending now, but the science behind them goes back decades. While these medications support weight management, rapid or significant changes can impact facial volume, skin laxity, and overall balance.⁠ ⁠ Emerge Weight Loss – GLP1

Clinical evidence specifically examining Ozempic use in Crohn's disease patients is limited

Alcohol, sweet bakery, snacks, and rich or heavy foods are particularly exposed, reflecting reduced tolerance and lower appetite for these products during active use

While significant weight loss can lead to a less voluminous and flatter derriere, the "Ozempic butt" phenomenon is not unique to this medication or even to the gluteus maximus

however, in the absence of adequate carbohydrates, bacteria may resort to alternative energy sources, forming potentially harmful metabolites that adversely affect human health [18]

Biol Med